News from the FDA/CDC
News from the FDA/CDC
Children and COVID: Weekly cases may have doubled in early January
Preliminary CDC data show an increase in new cases that was not reported by the American Academy of Pediatrics and the Children’s Hospital...
News from the FDA/CDC
Children and COVID: ED visits and hospitalizations start to fall again
CDC data show that weekly cases have been declining since early December.
News from the FDA/CDC
Children and COVID: New cases fell as the old year ended
Emergency department visits keep increasing as the pandemic’s death toll in children nears 2,000.
News from the FDA/CDC
CDC reports uptick in invasive Strep A infections
Consider this bacterial infection as a possible cause of severe illness in children and adults.
News from the FDA/CDC
Alzheimer’s Association to CMS: Ditch restraints on amyloid drugs
The CMS coverage restrictions for anti-amyloid drugs were finalized in April on the...
News from the FDA/CDC
Children and COVID: New-case counts offer dueling narratives
Data from the American Academy of Pediatrics appear to conflict with information provided by the Centers for Disease Control and Prevention.
News from the FDA/CDC
FDA approves Idacio as eighth adalimumab biosimilar in U.S.
Data for Idacio (adalimumab-aacf) showed safety, efficacy, and immunogenicity similar to Humira.
News from the FDA/CDC
Children and COVID: Hospitalizations provide a tale of two sources
Thanksgiving travel seems to have had little effect on new pediatric cases.
News
FDA OKs first fecal transplant therapy for recurrent C. difficile
The application for Rebyota received priority review and had orphan drug and breakthrough therapy designation.
Feature
U.S. flu activity already at mid-season levels
Nationally, 6% of all outpatient visits were because of flu or flu-like illness for the week of Nov. 13-19.
News from the FDA/CDC
FDA alert: ‘Substantial’ hypocalcemia risk with denosumab use in dialysis patients
The Food and Drug Administration sent an alert that it’s investigating an apparent link between the use of denosumab (Prolia) by patients on...